Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001700225-26-000004
Filing Date
2026-04-03
Accepted
2026-04-03 18:10:17
Documents
1
Period of Report
2026-04-02

Document Format Files

Seq Description Document Type Size
1 form4-04032026_100412.html 4  
1 form4-04032026_100412.xml 4 3495
  Complete submission text file 0001700225-26-000004.txt   5049
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Issuer) CIK: 0001427925 (see all company filings)

EIN.: 412193603 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address
Angotti Vincent J. (Reporting) CIK: 0001700225 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35068 | Film No.: 26839186